The biggest pharma stories this week covered drug approvals, vaccines, medical devices, wellness investments, and emerging health research. These pharma stories also showed how quickly healthcare priorities are changing across India and global...
Drug development could see a major shift as Huawei expands its artificial intelligence partnerships with pharmaceutical companies
FDA approval of updated COVID vaccines now lets manufacturers ship doses that target the XFG variant for the respiratory virus season
This article will explore pharma marketing KPIs that Indian companies should track, how marketing KPIs differ from sales KPIs, which metrics managers should monitor monthly, and how to measure pharma marketing ROI in India
Recent regulatory decisions show companies expanding access to innovative medicines while pursuing new markets and indications
Piramal Alternatives has invested Rs 215 crore in Kolors Healthcare as India’s wellness market sees rising demand for preventive and personalized healthcare. The investment will support Kolors’ expansion, infrastructure upgrades...
The US weight-loss drug market faces a new affordability challenge as employers reconsider coverage for GLP-1 medicines amid rising healthcare costs
The article shares how India’s pharmaceutical industry is moving beyond its traditional focus on high-volume generics. It explores the growing opportunities in peptides, sterile injectables and complex generics, while highlighting why skilled talent,
Recent developments from Johnson & Johnson, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Pulnovo Medical and Bayer highlight how pharmaceutical innovation, generic manufacturing and advanced medical technology strengthen critical care
Today's pharma news includes drug launches, USFDA approvals, and obesity drugs as global pharmaceutical companies push new treatments and expand manufacturing capacity
.jpg)
, CDSCO.jpg)